Turner, J. Rick.

Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance / [electronic resource] : J. Rick Turner, Todd A. Durham. - Hoboken, N.J. : John Wiley & Sons, c2009. - xxviii, 470 p. : ill.

Includes bibliographical references (p. 397-455) and index.

The importance of cardiac safety assessments -- The biological basis of adverse drug reactions -- Cardiac structure and function -- Cardiac pathophysiology and disease -- Drug discovery and drug design -- Nonclinical development -- The thorough QT/QTc trial -- General safety assessments -- Therapeutic use trials and meta-analyses -- Assessment methodologies in nonexperimental postmarketing surveillance -- Postmarketing proarrhythmic cardiac safety assessments -- Generalized cardiac safety -- Medication errors, adherence, and concordance -- Future directions in drug safety.


Electronic reproduction.
Palo Alto, Calif. :
ebrary,
2013.
Available via World Wide Web.
Access may be limited to ebrary affiliated libraries.

0470229640 (cloth) 9780470229644 (cloth)



DNLM


Cardiovascular toxicology.
Drugs--Safety measures.
Drugs--Side effects--Testing.
Heart--Effect of drugs on.


Electronic books.

RC677 / .T87 2009eb

616.1/23061